FDA Approved: JEVTANA — Original Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

The FDA approved JEVTANA (cabazitaxel) in the original NDA submitted by Sanofi-Aventis U.S. LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Jevtana (cabazitaxel)

Snippet

ORIG AP for JEVTANA (CABAZITAXEL)